194 related articles for article (PubMed ID: 6731633)
1. Elevated plasma tricyclic levels with therapeutic doses of imipramine.
Garvey MJ; Tuason VB; Johnson RA; Valentine RH; Cooper TB
Am J Psychiatry; 1984 Jul; 141(7):853-6. PubMed ID: 6731633
[TBL] [Abstract][Full Text] [Related]
2. Patterns of plasma imipramine-desipramine concentrations in patients receiving concomitant fluphenazine decanoate.
Siris SG; Adan F; Lee A; Cooper TB; Mandeli J; Casey E
J Clin Psychiatry; 1988 Feb; 49(2):64-5. PubMed ID: 3338977
[TBL] [Abstract][Full Text] [Related]
3. Fluvoxamine-induced alterations in plasma concentrations of imipramine and desipramine in depressed patients.
Spina E; Pollicino AM; Avenoso A; Campo GM; Caputi AP
Int J Clin Pharmacol Res; 1993; 13(3):167-71. PubMed ID: 8225700
[TBL] [Abstract][Full Text] [Related]
4. Excessive plasma concentration of tricyclic antidepressants resulting from usual doses: a report of six cases.
Devane CL; Wolin RE; Rovere RA; Panahon NC; Sutfin TA; Jusko WJ
J Clin Psychiatry; 1981 Apr; 42(4):143-7. PubMed ID: 7204359
[TBL] [Abstract][Full Text] [Related]
5. Depression in children: relationship between plasma imipramine levels and response.
Preskorn SH; Weller EB; Weller RA
J Clin Psychiatry; 1982 Nov; 43(11):450-3. PubMed ID: 7174621
[TBL] [Abstract][Full Text] [Related]
6. Association of graded allele-specific changes in CYP2D6 function with imipramine dose requirement in a large group of depressed patients.
Schenk PW; van Fessem MA; Verploegh-Van Rij S; Mathot RA; van Gelder T; Vulto AG; van Vliet M; Lindemans J; Bruijn JA; van Schaik RH
Mol Psychiatry; 2008 Jun; 13(6):597-605. PubMed ID: 17667959
[TBL] [Abstract][Full Text] [Related]
7. Plasma levels of imipramine and adverse effects in children.
Preskorn SH; Weller EB; Weller RA; Glotzbach E
Am J Psychiatry; 1983 Oct; 140(10):1332-5. PubMed ID: 6624965
[TBL] [Abstract][Full Text] [Related]
8. Interaction between fluvoxamine and imipramine/desipramine in four patients.
Spina E; Campo GM; Avenoso A; Pollicino MA; Caputi AP
Ther Drug Monit; 1992 Jun; 14(3):194-6. PubMed ID: 1412604
[TBL] [Abstract][Full Text] [Related]
9. Imipramine and tinnitus.
Tandon R; Grunhaus L; Greden JF
J Clin Psychiatry; 1987 Mar; 48(3):109-11. PubMed ID: 3818550
[TBL] [Abstract][Full Text] [Related]
10. [Clinical usefulness of monitoring serum levels of imipramine and desipramine in patients treated for endogenous depression].
Szymura-Oleksiak J; Wasieczko A
Psychiatr Pol; 1991; 25(1):54-60. PubMed ID: 1780375
[TBL] [Abstract][Full Text] [Related]
11. Plasma concentrations of tricyclic antidepressants in clinical practice.
Hollister LE
J Clin Psychiatry; 1982 Feb; 43(2):66-9. PubMed ID: 7056706
[TBL] [Abstract][Full Text] [Related]
12. The relationship of therapeutic response to antidepressant plasma levels: an update.
Friedel RO
J Clin Psychiatry; 1982 Nov; 43(11 Pt 2):37-43. PubMed ID: 7174630
[No Abstract] [Full Text] [Related]
13. ECG effects of comparable plasma concentrations of desipramine and amitriptyline.
Veith RC; Bloom V; Bielski R; Friedel RO
J Clin Psychopharmacol; 1982 Dec; 2(6):394-8. PubMed ID: 7174862
[TBL] [Abstract][Full Text] [Related]
14. Imipramine blood levels and clinical outcome.
Rigal JG; Albin HC; Duchier AR; D'Aulnay JM; Fenelon JH; Vincon GA; Demotes-Mainard FM
J Clin Psychopharmacol; 1987 Aug; 7(4):222-9. PubMed ID: 3624505
[TBL] [Abstract][Full Text] [Related]
15. Steady-state plasma imipramine levels in prepubertal depressed children.
Weller EB; Weller RA; Preskorn SH; Glotzbach R
Am J Psychiatry; 1982 Apr; 139(4):506-8. PubMed ID: 7065300
[No Abstract] [Full Text] [Related]
16. Tricyclic-resistant depression: treatment resistance or inadequate treatment?
Lydiard RB
J Clin Psychiatry; 1985 Oct; 46(10):412-7. PubMed ID: 3900051
[TBL] [Abstract][Full Text] [Related]
17. Tricyclic antidepressant plasma levels: the state of the art and clinical prospects.
Razavi D; Mendlewicz J
Neuropsychobiology; 1982; 8(2):73-85. PubMed ID: 7070646
[TBL] [Abstract][Full Text] [Related]
18. Relationship between plasma antidepressant levels and clinical outcome for inpatients receiving imipramine.
Simpson GM; White KL; Boyd JL; Cooper TB; Halaris A; Wilson IC; Raman EJ; Ruther E
Am J Psychiatry; 1982 Mar; 139(3):358-60. PubMed ID: 7036761
[No Abstract] [Full Text] [Related]
19. Active metabolites of imipramine and desipramine in man.
Potter WZ; Calil HM; Sutfin TA; Zavadil AP; Jusko WJ; Rapoport J; Goodwin FK
Clin Pharmacol Ther; 1982 Mar; 31(3):393-401. PubMed ID: 7060321
[TBL] [Abstract][Full Text] [Related]
20. Urinary desipramine hydroxylation index and steady-state plasma concentrations of imipramine and desipramine.
Spina E; Arena A; Pisani F
Ther Drug Monit; 1987 Jun; 9(2):129-33. PubMed ID: 3617150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
